Cite

Genotype and predicted phenotype prevalences of the CYP2C19 allelic variants in the population of the Republic of Srpska

Genotype Participants (N) Prevalence (%) Confidence interval (95 %) Predicted phenotype
CYP2C19*1/*1 89 41.20 34.57–48.08 normal metabolisers
CYP2C19*1/*2 39 18.05 13.17–23.85 intermediate metabolisers
CYP2C19*2/*17 13 6.02 3.24–10.07 intermediate metabolisers
CYP2C19*1/*3 - - - intermediate metabolisers
CYP2C19*3/*17 - - - intermediate metabolisers
CYP2C19*2/*2 9 4.17 1.92–7.76 poor metabolisers
CYP2C19*3/*3 - - - poor metabolisers
CYP2C19*2/*3 - - - poor metabolisers
CYP2C19*1/*17 57 26.39 20.64–32.80 rapid metabolisers
CYP2C19*17/*17 9 4.17 1.92–7.76 ultra-rapid metabolisers

Genotype and predicted phenotype prevalences of the CYP2C9 allelic variants in the population of the Republic of Srpska

Genotype Participants (N) Prevalence (%) Confidence interval (95 %) Predicted phenotype
CYP2C9*1/*1 134 62.03 55.20–68.53 normal metabolisers
CYP2C9*1/*2 47 21.76 16.45–27.86 intermediate metabolisers
CYP2C9*1/*3 26 12.04 8.02–17.14 intermediate metabolisers
CYP2C9*2/*2 5 2.31 0.76–5.32 intermediate metabolisers
CYP2C9*2/*3 2 0.93 0.11–3.30 poor metabolisers
CYP2C9*3/*3 2 0.93 0.11–3.30 poor metabolisers

Genotype and the prevalence of the CYP2C9 and CYP2C19 allelic variants in the population of the Republic of Srpska (RS) compared to other populations

Alleles frequencies
Gene Genotype Genotype frequency n (%) Alleles RS Bosnia and Herzegovina Macedonia Croatia Serbia Kosovo Slovenia Italy Greece Germany Russia Spain Eastern Asians African African-American
References (36) (37) (17) (8) (38) (25) (30) (26) (39) (40) (41) (24) (20) (22) (23) (16) (29) (29)
CYP2C9*2 *1/*1 162 (75) C 0.866 0.868 0.910 0.861 0.855 0.835 0.883 0.825 0.878 0.830 0.846 0.875 0.896 0.860 0.895 0.840 0.999 0.980 0.990
*1/*2 46 (21.29) - - - - - - - - - - - - - - - - - - - -
*2/*2 5 (2.31) T 0.134 0.132 0.090 0.139 0.145 0.165 0.117 0.175 0.122 0.170 0.154 0.125 0.104 0.140 0.105 0.160 0.0001 0.020 0.010
CYP2C9*3 *1/*1 186 (86.11) A 0.928 0.911 - 0.927 0.924 0.905 0.919 0.891 0.937 0.856 0.916 0.903 0.933 0.950 0.933 0.900 0.997 0.990 0.995
*1/*3 28 (12.96) - - - - - - - - - - - - - - - - - - - -
*3/*3 2 (0.93) c 0.072 0.089 - 0.073 0.076 0.095 0.081 0.109 0.063 0.144 0.084 0.097 0.067 0.050 0.067 0.100 0.003 0.010 0.005
CYP2C19*2 *1/*1 155 (71.76) G 0.847 - 0.830 0.856 0.852 0.850 0.837 0.870 0.841 - 0.907 0.889 0.869 - 0.886 - - - -
*1/*2 52 (24.07) - - - - - - - - - - - - - - - - - - - -
*2/*2 9 (4.17) A 0.153 - 0.170 0.144 0.148 0.150 0.163 0.130 0.159 - 0.093 0.111 0.131 - 0.114 - - - -
CYP2C19*3 *1/*1 216 (100) G 1.00 - - - - - - - 0.996 - - 1.00 1.00 - 0.997 - - - -
*1/*3 0 - - - - - - - - - - - - - - - - - - - -
*3/*3 0 A 0.00 - - - - - - - 0.004 - - 0.00 0.00 - 0.003 - - - -
CYP2C19*17 *1/*1 137 (63.42) C 0.796 - - 0.799 0.763 - 0.778 0.810 - - 0.776 - - - - - - - -
*1/*17 70 (32.41) - - - - - - - - - - - - - - - - - - - -
*17/*17 9 (4.17) T 0.204 - - 0.201 0.237 - 0.222 0.190 - - 0.224 - - - - - - - -
eISSN:
1848-6312
Idiomas:
Inglés, Slovenian
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Basic Medical Science, other